日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

血清 VEGF-A 作为转移性非小细胞肺癌化疗联合免疫治疗中加用贝伐单抗的生物标志物

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-58186-7
Tanaka, Kentaro; Sugisaka, Jun; Shiraishi, Yoshimasa; Watanabe, Yasutaka; Daga, Haruko; Azuma, Koichi; Nishino, Kazumi; Mori, Masahide; Ota, Takayo; Saito, Haruhiro; Hata, Akito; Sakaguchi, Tadashi; Kozuki, Toshiyuki; Akamatsu, Hiroaki; Matsumoto, Hirotaka; Tachihara, Motoko; Wakuda, Kazushige; Sato, Yuki; Ozaki, Tomohiro; Tsuchiya-Kawano, Yuko; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Okamoto, Isamu
肺癌
肿瘤
肿瘤免疫
EGF
VEGF-A
细胞生物学
VEGF
免疫/内分泌
发表日期：2025
文献求助 收藏

PD-1/PD-L1 checkpoint inhibitor-induced encephalitis in patients with lung adenocarcinoma: a report of three cases

PD-1/PD-L1检查点抑制剂诱发肺腺癌患者脑炎：三例报告

期刊:Oxford Medical Case Reports
影响因子:0.4
doi:10.1093/omcr/omae201
Ota, Takayo; Terashima, Masaaki; Hamada, Yukihiro; Ueno, Shuichi; Kawai, Shigeru; Tanaka, Noriko; Matsui, Kaoru; Masuda, Noriyuki
肿瘤
脑炎
肿瘤免疫
神经科学
PD-L1
PD-1
发表日期：2025
文献求助 收藏

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade

可溶性免疫检查点因子反映了抗肿瘤免疫的耗竭以及对PD-1阻断的反应。

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI168318
Hayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Goto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku
肿瘤
肿瘤免疫
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏

Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer

纳武利尤单抗联合卡铂加紫杉醇及同步胸部放疗治疗未经治疗的不可切除局部晚期非小细胞肺癌患者的可行性研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16183127
Yamanaka, Yuta; Ota, Takayo; Masuoka, Yutaka; Takeyasu, Yuki; Nakamura, Satoaki; Terashima, Masaaki; Yoshioka, Hiroshige; Fukuoka, Masahiro; Kurata, Takayasu
肿瘤免疫
肺癌
细胞生物学
肿瘤
发表日期：2024
文献求助 收藏

Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations

全面的激酶活性分析揭示了EGFR酪氨酸激酶抑制剂治疗对携带EGFR敏感突变的晚期非小细胞肺癌患者疗效相关的激酶活性模式

期刊:Proteomes
影响因子:3.6
doi:10.3390/proteomes11010006
Noguchi, Rei; Yoshimura, Akihiro; Uchino, Junji; Takeda, Takayuki; Chihara, Yusuke; Ota, Takayo; Hiranuma, Osamu; Gyotoku, Hiroshi; Takayama, Koichi; Kondo, Tadashi
肺癌
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏

Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature

甲胎蛋白阳性胃癌患者行全胃切除术后接受纳武利尤单抗序贯伊立替康治疗的长期生存：病例报告及文献复习

期刊:Surgical Case Reports
影响因子:0.7
doi:10.1186/s40792-023-01653-4
Ota, Takayo; Sakashita, Katsuya; Sawada, Ryugo; Seki, Kurumi; Maeda, Hiroyuki; Tanaka, Noriko; Tsujinaka, Toshimasa
胃癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E-mutated lung adenocarcinoma

BRAF V600E突变型肺腺癌对达拉非尼和曲美替尼的反应迅速而显著

期刊:Respirology Case Reports
影响因子:0.8
doi:10.1002/rcr2.841
Ota, Takayo; Okabayashi, Aya; Fukuoka, Masahiro
肿瘤
BRAF
肿瘤免疫
发表日期：2021
文献求助 收藏

Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarker

非小细胞肺癌抗PD-1抗体治疗首个疗程期间血清免疫调节剂：穿孔素作为生物标志物

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13650
Ota, Takayo; Fukui, Tomoya; Nakahara, Yoshiro; Takeda, Takayuki; Uchino, Junji; Mouri, Takako; Kudo, Keita; Nakajima, Saki; Suzumura, Tomohiro; Fukuoka, Masahiro
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
免疫/内分泌
发表日期：2020
文献求助 收藏

False-Positive Elevation of CK-MB Levels with Chest Pain in Lung Adenocarcinoma

肺腺癌胸痛伴CK-MB水平假阳性升高

期刊:Case Reports in Oncology
影响因子:0.7
doi:10.1159/000505724
Ota, Takayo; Hasegawa, Yoshikazu; Murata, Eriko; Tanaka, Noriko; Fukuoka, Masahiro
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Porous diaphragm syndrome with recurrent thymoma

伴有复发性胸腺瘤的多孔性膈肌综合征

期刊:Respirology Case Reports
影响因子:0.8
doi:10.1002/rcr2.391
Ota, Takayo; Hasegawa, Yoshikazu; Okabe, Takafumi; Okimura, Akira; Fukuoka, Masahiro
胸腺瘤
发表日期：2019
文献求助 收藏